BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29979296)

  • 1. Ultra-long-acting insulins: A review of efficacy, safety, and implications for practice.
    J Am Assoc Nurse Pract; 2018 Jul; 30(7):381-382. PubMed ID: 29979296
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-long-acting insulins: A review of efficacy, safety, and implications for practice.
    Davis CS; Fleming JW; Malinowski SS; Brown MA; Fleming LW
    J Am Assoc Nurse Pract; 2018 Jul; 30(7):373-380. PubMed ID: 29979295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Newer Long-Acting Insulins on Hypoglycemia and Fracture Risk Among People with Diabetes: A Systematic Review.
    Hangaard S; Jensen MH
    Curr Osteoporos Rep; 2021 Dec; 19(6):637-643. PubMed ID: 34741730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of diabetic cats with long-acting insulin.
    Roomp K; Rand JS
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):251-66. PubMed ID: 23522171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 1():S43-55. PubMed ID: 26836429
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycemia in Diabetes Mellitus.
    Home Healthc Now; 2017 Sep; 35(8):E1-E2. PubMed ID: 28857877
    [No Abstract]   [Full Text] [Related]  

  • 7. The evolution of insulin therapy in diabetes mellitus.
    Heile M; Schneider D
    J Fam Pract; 2012 May; 61(5 Suppl):S6-12. PubMed ID: 22577636
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in insulin therapy: a review of insulin degludec.
    King A
    J Fam Pract; 2012 May; 61(5 Suppl):S28-31. PubMed ID: 22577639
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Acting Basal Insulins: A Review of the More Recently Approved Agents.
    Gallegos Aragon K; Elmaoued AA; Pham NT; Conklin JR; Ray GM
    Cardiol Rev; 2019; 27(5):260-266. PubMed ID: 31393288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin detemir, does a new century bring a better basal insulin?
    Hordern SV; Russell-Jones DL
    Int J Clin Pract; 2005 Jun; 59(6):730-9. PubMed ID: 15924603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications.
    Haque M; Islam S; Kamal ZM; Akter F; Jahan I; Rahim MSA; Sultana N; Alam AM; Munzur-E-Murshid ; Halim-Khan MA; Deeba F; Bakar MA; Nahar S; Mozaffor M; Urmi UL; Saikat TR; Islam MZ; Haque M; Iqbal S; Hossain MM; Naher N; Allocati E; Godman B
    Hosp Pract (1995); 2021 Oct; 49(4):266-272. PubMed ID: 33734004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic compliance and flexibility in the use of basal insulins].
    Costa Gil JE; Litwak LE; Fuente GV; Faingold MC
    Medicina (B Aires); 2014; 74(4):273-81. PubMed ID: 25188652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEW FOR YOU! These innovative products aim to help make diabetes self-management easier.
    Wynn P
    Diabetes Self Manag; 2017 Mar; 34(2):24-7, 31. PubMed ID: 29757530
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
    Goldman J; Kapitza C; Pettus J; Heise T
    Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and Emerging Insulin Preparations for Type 2 Diabetes.
    Cheung KK; Alexander P
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S160-6. PubMed ID: 26653255
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-acting insulins in the treatment of type 2 diabetes and their position in the current treatment algorithm].
    Haluzík M
    Vnitr Lek; 2017; 63(2):87-92. PubMed ID: 28334539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin analogues and management of diabetes mellitus.
    Vaidyanathan B; Menon PS
    Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin glargine.
    Bolli GB; Owens DR
    Lancet; 2000 Aug; 356(9228):443-5. PubMed ID: 10981882
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing Hypoglycemia in Critical Care Patients Using a Nurse-Driven Root Cause Analysis Process.
    Shea KE; Gerard SO; Krinsley JS
    Crit Care Nurse; 2019 Aug; 39(4):29-38. PubMed ID: 31371365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.